[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356230-105":59,"doc-detail-356230-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","leveraging-genetic-instrumental-variables-and-sequencing-analysis-to-identify-a-prognostic-signature-based-on-epithelial-cell-markers-in-lung-adenocarcinoma-abstract-methods-results-conclusions","Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma - Abstract, Methods, Results, Conclusions","","Study targets the persistent challenge of predicting treatment response and outcomes for lung adenocarcinoma (LUAD) by identifying prognostic genes and building a prognostic model. Malignant alveolar type II (AT2) cells were identified using InferCNV, then CytoTRACE, pseudo-time analysis, Mendelian randomization, and univariate Cox regression were applied to define prognostic genes. An optimized LASSO subset produced four prognostic genes and was validated in external cohorts. High-risk patients showed significantly worse overall survival (p \u003C 0.01).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/leveraging-genetic-instrumental-variables-and-sequencing-analysis-to-identify-a-prognostic-signature-based-on-epithelial-cell-markers-in-lung-adenocarcinoma-abstract-methods-results-conclusions/356230/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/leveraging-genetic-instrumental-variables-and-sequencing-analysis-to-identify-a-prognostic-signature-based-on-epithelial-cell-markers-in-lung-adenocarcinoma-abstract-methods-results-conclusions/356230.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on LUAD?","Question",{"text":112,"@type":113},"To identify prognostic genes and construct a prognostic model that predicts outcomes for lung adenocarcinoma patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic genes identified and narrowed down?",{"text":117,"@type":113},"Malignant AT2 cells were identified using InferCNV, followed by CytoTRACE, pseudo-time analysis, Mendelian randomization, and univariate Cox regression; the final gene subset was selected using LASSO.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance and validation evidence is reported for the prognostic model?",{"text":121,"@type":113},"The model reached AUC values around 0.649–0.675 for 1–3 year overall survival predictions in the training set and was validated in two external cohorts at corresponding time points.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356230,1790146397,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Thoracic Cancer   \n ORIGINAL ARTICLE  OPEN ACCESS   \nLeveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma  \nJiaye Lao1,2 | Ziqing Han1,2 | Xinjing Lou1,2 | Jinxuan Ye1,2 | Chen Gao1,2  | Linyu Wu1,2  \n1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China | 2The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China  \nCorrespondence: Chen Gao ([doctor_gaochen@zcmu.edu.cn](doctor_gaochen@zcmu.edu.cn)) | Linyu Wu ([wulinyu@zcmu.edu.cn](wulinyu@zcmu.edu.cn))  \nReceived: 4 July 2025 | Revised: 27 November 2025 | Accepted: 2 January 2026  \nKeywords: bulk RNA sequencing | lung adenocarcinoma | Mendelian randomization | prognostic signature | single-cell RNA sequencing  \nABSTRACT  \nMain Problem: The treatment and prognosis of lung adenocarcinoma (LUAD) remain challenging. The study aimed to identify prognostic genes and construct a prognostic model for LUAD.  \nMethods: After identifying malignant alveolar type II (AT2) cells using InferCNV, we applied CytoTRACE, pseudo-time analysis, Mendelian randomization (MR), and univariate Cox regression analysis to identify prognostic genes. A prognostic model was then developed using an optimized subset of these genes, selected through the least absolute shrinkage and selection operator (LASSO) algorithm. Further analyses included Gene Ontology enrichment analysis and the construction of a protein–protein interaction (PPI) network.  \nResults: Pseudo-time analysis identified 3526 dynamically expressed genes during malignant AT2 cell dedifferentiation. Subsequent multi-omics integration refined the gene selection, yielding four prognostic genes for the final predictive model. The resulting model achieved area under the receiver operating characteristic (ROC) curve (AUC) values of 0.649, 0.675, and 0.654 for predicting 1, 2, and 3-year overall survival (OS) in the training set, respectively, and was successfully validated in two external cohorts at the corresponding time points. Moreover, survival analysis demonstrated that patients in the high-risk group had significantly poorer OS than those in the low-risk group, both in the training set and the validation sets (p \u003C 0.01) .  \nConclusions: The study developed a novel signature based on genes dynamically expressed during malignant AT2 cell dedifferentiation, capable of predicting the prognosis ofLUAD patients, and offered four accurate prognostic biomarkers (ADM, MARK4, PARVA, andRPS6KA1) .  \n\n| Abbreviations: 1KGP, the 1000 Genomes Project; AHR, aryl hydrocarbon receptor; AT1, alveolar type I; AT2, alveolar type II; AUC, area under the receiver operating characteristic curve; CNVs, copy number variations; DAPS, Dedifferentiation-Associated Prognostic Signature; DEGs, differentially expressed genes; DTCNV, dynamic transition copy number variation; DTSL, dynamic transition stemness level; FTO, fat mass and obesity-associated protein; GEO, gene expression omnibus; GO, Gene Ontology; GWAS, genome-wide association study; HARPs, hyperacute response proteins; HCNV, high copy number variation; HEIDI, heterogeneity of dependent instruments; HSL, high stemness level; KNN, K-nearest neighbors; LASSO, the least absolute shrinkage and selection operator; LCNV, low copy number variation; LSL, low stemness level; LUAD, lung adenocarcinoma; MAF, minor allele frequency; MR, Mendelian randomization; OS, overall survival; PCA, principal component analysis; PCs, principal components; PPI, protein–protein interaction; ROC, receiver operating characteristic; scRNA-seq, single-cell RNA sequencing; SMR, summary-data-based Mendelian randomization; SNP, single-nucleotide polymorphism.\u003Cbr>Jiaye Lao and Ziqing Han contributed equally to this study. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which","cbCaiv5OgbIm1Ac6","https://ap.wps.com/l/cbCaiv5OgbIm1Ac6","pdf",6126121,14,"English","# Abstract\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Background and clinical need","[{\"question\":\"What is the main goal of the study on LUAD?\",\"answer\":\"To identify prognostic genes and construct a prognostic model that predicts outcomes for lung adenocarcinoma patients.\"},{\"question\":\"How were prognostic genes identified and narrowed down?\",\"answer\":\"Malignant AT2 cells were identified using InferCNV, followed by CytoTRACE, pseudo-time analysis, Mendelian randomization, and univariate Cox regression; the final gene subset was selected using LASSO.\"},{\"question\":\"What performance and validation evidence is reported for the prognostic model?\",\"answer\":\"The model reached AUC values around 0.649–0.675 for 1–3 year overall survival predictions in the training set and was validated in two external cohorts at corresponding time points.\"}]","Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma - Abstract, Methods, Results, Conclusions | PDF",1790124190,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f13d31277aca35d130d2db9f828fcf6d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e44168c3b64e123c4f7fec46cb65c7c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67b79f6581f59402d06b7e4544eff75b.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e30e2d2b895614e9c9e06b2b3493d80.webp",980,1287]